TYRA
Tyra Biosciences, Inc.
$30.62
+1.21 (+4.11%)
At close · Jul 2
Market Cap
$1.82B
Shares
59,470,381
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Todd Harris | CEO | $5,566,997 |
| Bhavesh Ashar | COO | $4,685,274 |
| Douglas Warner | — | $2,372,243 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Todd Harris | CEO | $7,570,066 |
| Douglas Warner | — | $4,725,517 |
| Daniel Bensen | COO | $2,655,199 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Todd Harris | CEO | $4,626,119 |
| Alan Fuhrman | CFO | $3,530,805 |
| Hiroomi Tada | — | $2,412,417 |
| Daniel Bensen | COO | $1,919,933 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| General Counsel | — | $2,624,708 |
| Daniel Bensen | COO | $2,429,639 |
| Todd Harris | CEO | $2,287,534 |
| Hiroomi Tada | — | $1,266,737 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Todd Harris | CEO | $6,377,563 |
| Ronald V. Swanson | — | $2,527,901 |
| Hiroomi Tada | — | $2,511,361 |
| Daniel Bensen | COO | $2,450,780 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Todd Harris | CEO | $1,238,836 |
| Ronald V. Swanson | — | $487,024 |